EPO Patents = 2

Forward Citations = 1

Loading Chart...

8 inventors (with patents filed for the assignee):

Woo Jin Park (6 out of 12 patents)

Tae Hwan Kwak (2 out of 6 patents)

Jae Gyun Oh (2 out of 3 patents)

4. Roger J Hajjar (1 out of 8 patents)

5. Dong Kwon Yang (1 out of 1 patent)

6. Pyoung Oh Yoon (1 out of 1 patent)

7. Seung Pil Jang (1 out of 1 patent)

8. Min-Ah Lee (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12215362 - Pharmaceutical composition for prevention or treatment of heart failure (2025-02-04),

2. 11761019 - Pharmaceutical composition for preventing or treating cardiac arrhythmia (2023-09-19),

3. 11426441 - Composition comprising protein phosphatase 1 inhibitory peptide for treating vascular diseases (2022-08-30),

4. RE48636 - Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban (2021-07-12),

5. 10479816 - Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban (2019-11-19),

6. 9855315 - Pharmaceutical composition comprising CCN5 for reducing cardiac fibrosis in a subject in need thereof (2018-01-02),

Bethphagen Inc. is a leading biotechnology company focused on developing innovative therapies for rare genetic disorders. With a team of dedicated scientists and researchers, Bethphagen is committed to improving the lives of patients by advancing cutting-edge treatments and technologies. Our mission is to bring hope and healing to those affected by rare diseases through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#20 in Gwangju

#1,538 in South Korea

Gwangju, South Korea

Bethphagen Inc.